Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on: January 14,2025

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on:January 14,2025

Our minds may process language like chatbots, study reveals

byHebrew University of JerusalemZero-shot encoding and decoding analysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46631-yA recent study has found fascinating simi

Updated on: November 28,2024

Our minds may process language like chatbots, study reveals

byHebrew University of JerusalemZero-shot encoding and decoding analysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46631-yA recent study has found fascinating simi

Updated on:November 28,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on: February 26,2024

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Updated on:February 26,2024

Uncovering factors that drive depression after a stroke

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainAfter a stroke, many people develop depression that is driven by factors including cognitive difficulties, a lack of socia

Updated on: November 06,2024

Uncovering factors that drive depression after a stroke

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainAfter a stroke, many people develop depression that is driven by factors including cognitive difficulties, a lack of socia

Updated on:November 06,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on: October 16,2024

Visual mismatch negativity identified as a mechanism of Parkinson's disease psychosis

byKing's College LondonGraphical Abstract. Credit:Brain Communications(2024). DOI: 10.1093/braincomms/fcae291Reduced brain activity responding to unpredicted visual changes is a

Updated on:October 16,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on: March 07,2024

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

Updated on:March 07,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on: April 01,2024

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Updated on:April 01,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on: March 07,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on:March 07,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on: February 28,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on:February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

New template of the human brain enhances neuroimaging data analysis

byDartmouth CollegeVariation in vertex properties across the cortex.a, The distribution of vertices in fsavg, fslr and onavg, as measured by inter-vertex distance.b, Standard deviati

Updated on: July 17,2024

New template of the human brain enhances neuroimaging data analysis

byDartmouth CollegeVariation in vertex properties across the cortex.a, The distribution of vertices in fsavg, fslr and onavg, as measured by inter-vertex distance.b, Standard deviati

Updated on:July 17,2024